EZH2 (SP129)

< Back
up arrow
Western Blot analysis of HeLa cell lysate with EZH2 antibody
Human prostate cancer stained with anti-EZH2 antibody
Flow cytometric analysis of rabbit anti-EZH2 (SP129) antibody in HeLa (green) compare to negative control of rabbit IgG (blue)
down arrow
Human prostate cancer stained with anti-EZH2 antibody

Human prostate cancer stained with anti-EZH2 antibody

QuantityCatalog No.VolumeDilutionPrice
M42917.0ml $385

KMT6 / Enhancer of zeste homologue 2 (EZH2) is a histone lysine methyl transferase associated with transcriptional repression. It is a component of the polycomb repressive complexes PRC2 and PRC3. The PRC2 complex catalyses histone H3 K27 trimethylation. EZH2 is ubiquitously expressed during early embryo genesis, and becomes restricted to the central and peripheral nervous systems and sites of fetal hematopoiesis during later development. EZH2 is highly expressed in follicular T-cells and in a variety of tumors such as lymphoma, breast and prostate.

Product Specification Sheets:


Product Details:

  • TechnologyRabbit Monoclonal
  • Clone NameSP129
  • ApplicationIHC-P, WB, FACS
  • Species Reactivity
  •   TestedHu
  •   Predicted by homologyMs, Rt, Fg, Mk
  • IsotypeRabbit IgG
  • ImmunogenSynthetic peptide corresponding to the C-terminus of human EZH2 protein.
  • Cellular LocalizationNucleus
  • Control TissueTonsil, Prostate Carcinoma
  • Regulatory RatingResearch Use Only (RUO)
  • Entrez2146
  • Storage Requirement2-8°C
  • Target Molecular Weight98 kDa
  • FormulationRefer to Data Sheet